obinutuzumab

obinutuzumab
Trade Name Gazyva
Orphan Indication Follicular lymphoma
USA Market Approval USA
USA Designation Date 2015-04-15 00:00:00
Sponsor Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080
Related Access Program
Kite, A Gilead Company – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Transformed Follicular Lymphoma